Cargando…

Stromal SPOCK1 supports invasive pancreatic cancer growth

Pancreatic ductal adenocarcinoma (PDAC) is marked by an abundant stromal deposition. This stroma is suspected to harbor both tumor‐promoting and tumor‐suppressing properties. This is underscored by the disappointing results of stroma targeting in clinical studies. Given the complexity of tumor–strom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veenstra, Veronique L., Damhofer, Helene, Waasdorp, Cynthia, Steins, Anne, Kocher, Hemant M., Medema, Jan P., van Laarhoven, Hanneke W., Bijlsma, Maarten F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537700/ https://www.ncbi.nlm.nih.gov/pubmed/28486750 http://dx.doi.org/10.1002/1878-0261.12073

Ejemplares similares

Patched-2 functions to limit Patched-1 deficient skin cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2018)

High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
por: Steins, Anne, et al.
Publicado: (2020)

Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer
por: Veenstra, Veronique L., et al.
Publicado: (2018)

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
por: Veenstra, V. L., et al.
Publicado: (2018)

Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
por: Dijk, Frederike, et al.
Publicado: (2020)

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
por: Steins, Anne, et al.
Publicado: (2017)

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
por: Liu, Dajia, et al.
Publicado: (2020)

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
por: Ebbing, Eva A., et al.
Publicado: (2019)

Java testing with Spock
por: Kapelonis, Konstantinos
Publicado: (2016)

Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
por: ten Hoorn, Sanne, et al.
Publicado: (2022)

Spock, 'frito' en segundos
Publicado: (2010)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract
por: Damhofer, Helene, et al.
Publicado: (2015)

Complete Genome of Bacillus thuringiensis Myophage Spock
por: Maroun, Justin W., et al.
Publicado: (2013)

SPOCK1 Promotes the Development of Hepatocellular Carcinoma
por: Váncza, Lóránd, et al.
Publicado: (2022)

SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
por: Aghamaliyev, Ughur, et al.
Publicado: (2023)

SPOCK1 promotes tumor growth and metastasis in human prostate cancer
por: Chen, Qi, et al.
Publicado: (2016)

Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma
por: Váncza, Lóránd, et al.
Publicado: (2023)

Rapid stromal remodeling by short‐term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2020)

Spock, up and running: writing expressive tests in Java and Groovy
por: Fletcher, Rob
Publicado: (2017)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug‐induced epithelial‐mesenchymal transition
por: Chen, Dehu, et al.
Publicado: (2017)

Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation
por: Tekin, Cansu, et al.
Publicado: (2020)

MicroRNA-155-5p inhibits the invasion and migration of prostate cancer cells by targeting SPOCK1
por: Yao, Lin-Ya, et al.
Publicado: (2020)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway
por: Zhao, Ping, et al.
Publicado: (2016)

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: van Mackelenbergh, Madelaine G., et al.
Publicado: (2019)

Multiomic analysis of the function of SPOCK1 across cancers: an integrated bioinformatics approach
por: Han, Jie, et al.
Publicado: (2021)

SPOCK1 Is a Novel Transforming Growth Factor-β–Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer
por: Fan, Li-Ching, et al.
Publicado: (2016)

Upregulation of SPOCK2 inhibits the invasion and migration of prostate cancer cells by regulating the MT1-MMP/MMP2 pathway
por: Liu, Gang, et al.
Publicado: (2019)

SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?
por: Sun, Li-rui, et al.
Publicado: (2020)

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
por: Perurena, Naiara, et al.
Publicado: (2017)

High SPOCK1 Expression Is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer
por: Chen, Mei-Ling, et al.
Publicado: (2019)

SPOCK1 is a novel inducer of epithelial to mesenchymal transition in drug-induced gingival overgrowth
por: Alshargabi, Rehab, et al.
Publicado: (2020)

SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Zhao, Jinming, et al.
Publicado: (2020)

Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma
por: Luo, Wenyi, et al.
Publicado: (2022)

Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients
por: Jiao, Mi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08pjk9jajpkdoepoottalj592v